Galectin Therapeutics Inc (GALT)
0.8901
-0.15
(-14.41%)
USD |
NASDAQ |
Dec 23, 16:00
0.86
-0.03
(-3.38%)
Pre-Market: 08:04
Galectin Therapeutics Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median